当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析 - 资产负债表

华海药业

(600521)

  

流通市值:244.65亿  总市值:244.65亿
流通股本:14.97亿   总股本:14.97亿

资产负债表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
流动资产:
  货币资金1,886,366,649.751,897,240,615.061,504,291,385.011,420,023,169.52
  交易性金融资产75,225,183.4277,471,707.2375,981,438.9692,218,690.26
  应收票据及应收账款2,971,926,445.732,719,801,359.742,867,724,799.292,820,719,979.35
        应收账款2,971,926,445.732,719,801,359.742,867,724,799.292,820,719,979.35
  应收款项融资195,837,786.6315,446,420.62304,505,039.62189,502,614.94
  预付款项77,525,066.2384,260,007.8276,422,532.9697,459,190.01
  其他应收款合计13,921,995.06325,686,759.4440,041,383.4132,501,910.61
  存货3,596,336,010.533,645,986,136.83,712,409,370.543,813,635,900.31
  其他流动资产147,723,821.1152,951,176.81160,897,926.3181,889,392.31
  流动资产合计8,964,862,958.429,218,844,183.528,742,273,876.098,647,950,847.31
非流动资产:
  长期股权投资468,673,677.89511,142,989.1373,386,244.11368,123,070.6
  其他权益工具投资35,149.4635,149.4635,149.4635,149.46
  其他非流动金融资产404,845,893.66399,922,381.93396,637,511.7390,002,469.72
  投资性房地产857,974.81867,914.77877,854.73887,794.69
  固定资产7,320,342,807.897,363,678,583.417,380,372,221.987,036,723,852.58
  在建工程2,217,358,645.372,160,862,231.631,987,104,097.652,109,725,463.69
  使用权资产16,276,963.8542,691,502.88105,015,121104,590,928.14
  无形资产1,129,430,496.471,140,318,174.821,158,411,475.211,183,002,080.77
  开发支出1,133,879,174.391,087,989,503.231,063,123,404.341,029,775,160.98
  商誉65,839,528.4964,445,908.0664,445,908.0664,445,908.06
  长期待摊费用34,971,118.9531,838,640.134,445,072.7933,021,788.41
  递延所得税资产186,087,726.77192,090,689.24194,778,922.56183,694,795.13
  其他非流动资产1,942,156.351,517,628.052,056,919.7712,285.86
  非流动资产合计12,980,541,314.3512,997,401,296.6812,760,689,903.2912,504,740,748.09
  资产总计21,945,404,272.7722,216,245,480.221,502,963,779.3821,152,691,595.4
流动负债:
  短期借款2,692,409,227.193,109,981,937.872,860,322,221.062,603,028,174.57
  应付票据及应付账款1,550,288,753.341,617,442,042.921,806,914,403.691,684,883,190.62
  其中:应付票据428,268,094.69537,711,955.93626,645,387.55577,906,671.24
        应付账款1,122,020,658.651,079,730,086.991,180,269,016.141,106,976,519.38
  合同负债64,498,201.4338,439,663.2234,987,956.3234,640,027.16
  应付职工薪酬175,211,519.2182,333,912.44340,639,000.63205,616,554.92
  应交税费121,169,883.82102,448,783.37126,388,246.9397,770,873.53
  其他应付款合计816,083,199.54754,589,620.59679,281,319.77783,861,208.99
  一年内到期的非流动负债3,135,061,420.933,297,384,922.673,260,748,221.541,121,632,376.03
  其他流动负债3,534,912.582,098,944.93,102,061.992,681,184.74
  流动负债合计8,558,257,118.039,104,719,827.989,112,383,431.936,534,113,590.56
非流动负债:
  长期借款2,373,270,265.152,238,012,5001,841,052,5001,954,375,000
  应付债券---1,953,374,101.23
  租赁负债5,260,302.2224,686,026.5575,635,798.7274,004,209.94
  长期应付款214,328,767.15211,835,616.46209,369,863.03206,849,315.08
  预计负债82,973,654.95131,961,653.8139,644,169.94141,819,596.86
  递延收益659,318,690.91643,518,072.69661,835,092.13684,793,029.32
  其他非流动负债7,006,261.497,006,261.497,006,261.493,777,750
  非流动负债合计3,342,157,941.873,257,020,130.992,934,543,685.315,018,993,002.43
  负债合计11,900,415,059.912,361,739,958.9712,046,927,117.2411,553,106,592.99
所有者权益(或股东权益):
  实收资本(或股本)1,497,252,1961,497,252,1361,497,252,1361,497,251,442
  其他权益工具240,129,744240,129,874.34240,129,874.34240,132,872.08
  资本公积1,337,527,422.771,612,133,180.651,610,398,175.981,559,527,174.36
  减:库存股100,005,113.91100,005,113.91100,005,113.91100,005,113.91
  其他综合收益-16,344,713.75-4,833,525.67-3,158,793.08726,231.07
  专项储备3,270,086.743,239,961.63,200,382.323,316,969.25
  盈余公积752,684,367.04752,684,367.04752,684,367.04745,795,769.54
  未分配利润6,064,070,075.15,846,358,3515,442,182,781.185,563,180,324.72
  归属于母公司股东权益合计9,778,584,063.999,846,959,231.059,442,683,809.879,509,925,669.11
  少数股东权益266,405,148.887,546,290.1813,352,852.2789,659,333.3
  股东权益合计10,044,989,212.879,854,505,521.239,456,036,662.149,599,585,002.41
  负债和股东权益合计21,945,404,272.7722,216,245,480.221,502,963,779.3821,152,691,595.4
公告日期2026-08-272026-04-302026-04-302025-10-31
审计意见(境内)标准无保留意见
TOP↑